Results 321 to 330 of about 635,202 (354)

Insulin-like Growth Factor-1

2012
Strange, disturbing quality to subjects’ dream life. Difficulty concentrating. Headache in the forehead. Nasal congestion. Cramping abdominal pain associated with diarrhea or stool. Constipation with ineffectual urging. Strong uterine cramping with the menses. Premenstrual breast tenderness and swelling. Nausea. An aversion to chocolate and sweets.
openaire   +1 more source

Elevated insulin‐like growth factor‐1 in Cushing’s disease

Clinical Endocrinology, 2019
SummaryObjectiveTo determine if patients with untreated Cushing's disease have higher serum insulin‐like growth factor‐1 (IGF‐1) compared to matched controls, and if IGF‐1 decreases following remission of Cushing's disease.DesignRetrospective case‐control study matching Cushing's disease cases to control patients for adenoma size, age, sex, diabetic ...
Katherine English, Viral Chikani, Goce Dimeski, Warrick J. Inder   +3 more
openaire   +3 more sources

Peripheral insulin-like growth factor 1 in bipolar disorder

Psychiatry Research, 2017
Bipolar disorder is a recurrent and highly incapacitating illness, related to inflammation and changes in the insulin-like growth factor 1 (IGF-1). The objective of this study was to evaluate serum levels of IGF-1 in bipolar disorder patients and its relation to inflammation. We included 31 patients with bipolar disorder and 33 healthy controls.
Emily G, da Silva, Bianca, Pfaffenseller, Julio, Walz, Laura, Stertz, Gabriel, Fries, Adriane R, Rosa, Pedro V, Magalhães   +6 more
openaire   +2 more sources

Expression of insulin‐like growth factor 1 in sarcomas

Histopathology, 1990
The expression of insulin‐like growth factor‐1 (IGF‐1) was studied in normal tissues, in eight benign lesions and in 50 sarcomas. In palmar fibromatosis the spindle cells in cell‐dense areas exhibited a strong immunoreactivity. IGF‐1 was variably found in leiomyosarcomas (7/8), malignant schwannomas (7/9), synovial sarcomas (2/3), liposarcomas (3/6 ...
P J, Roholl, A, Skottner, I, Prinsen, C J, Lips, W, Den Otter, J A, Van Unnik   +5 more
openaire   +2 more sources

Insulin-Like Growth Factor 1 in the Cardiovascular System

2018
Non-communicable diseases, such as cardiovascular diseases, are the leading cause of mortality worldwide. For this reason, a tremendous effort is being made worldwide to effectively circumvent these afflictions, where insulin-like growth factor 1 (IGF1) is being proposed both as a marker and as a central cornerstone in these diseases, making it an ...
Gabriel A, Aguirre, José Luis, González-Guerra, Luis, Espinosa, Inma, Castilla-Cortazar   +3 more
openaire   +2 more sources

Insulin‐Like Growth Factor‐1

Journal of the American Geriatrics Society, 2004
Colbert, L. H., Rosen, C., Goodpaster, B. H., Newman, A. B., Kritchevsky, S. B., Satterfield, S., Kanaya, A. M., Taaffe, D. R., Harris, T. B.   +8 more
openaire   +3 more sources

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Insulin-like growth factor-1

2021
openaire   +1 more source

Cancer treatment and survivorship statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Kimberly D Miller, Leticia M Nogueira, Angela B Mariotto   +2 more
exaly  

Insulin-like Growth Factor-1

2006
ITAY BENTOV, HAIM WERNER
openaire   +1 more source